Enfusion's market cap is currently $1.46B. The company's EPS TTM is $0.026; its P/E ratio is 438.93; Enfusion is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 174.53M	$ 150.35M	$ 111.70M	$ 79.56M	$ 59.03M
Gross Profit	$ 116.89M	$ 103.25M	$ 79.86M	$ 58.21M	$ 42.07M
Operating Income	$ 11.95M	$ -11.96M	$ -275.88M	$ 6.07M	$ 13.87M
EBITDA	$ 21.93M	$ -5.62M	$ -271.91M	$ 8.37M	$ 15.02M
Net Income	$ 6.03M	$ -13.26M	$ -282.24M	$ 4.06M	$ 12.66M
Balance Sheet
Cash & Short-Term Investments	$ 35.60M	$ 62.55M	$ 64.36M	$ 13.94M	$ 5.90M
Total Assets	$ 108.97M	$ 123.78M	$ 106.08M	$ 39.10M	$ 23.20M
Total Debt	$ 15.44M	$ 6.99M	$ 0.00	$ 98.56M	$ 27.66M
Net Debt	$ -20.17M	$ -55.56M	$ -64.36M	$ 84.63M	$ 21.76M
Total Liabilities	$ 31.49M	$ 20.34M	$ 8.64M	$ 272.66M	$ 141.08M
Stockholders' Equity	$ 53.67M	$ 65.01M	$ 55.29M	$ -233.56M	$ -117.88M
Cash Flow
Free Cash Flow	$ 15.96M	$ 6.22M	$ -8.33M	$ -3.40M	$ 7.88M
Operating Cash Flow	$ 25.63M	$ 14.16M	$ -318.00K	$ 1.67M	$ 12.31M
Investing Cash Flow	$ -9.67M	$ -7.93M	$ -8.01M	$ -5.07M	$ -4.43M
Financing Cash Flow	$ -43.08M	$ -7.96M	$ 58.85M	$ 11.56M	$ -7.54M

Currency in USD

Enfusion Earnings and Revenue History

Income Statement >

Enfusion Debt to Assets

Balance Sheet >

Enfusion Cash Flow

Cash Flow >

Enfusion Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing